Digestive Enzyme Therapy cure illnesses

If you are looking for new alternative medications to a lot of illnesses then this article is just right for you.

Digestive enzymes are needed in order for us to be alive. This is the first reason why we should have digestive enzyme therapy. Digestive enzymes purify our blood, cleanse the colon, maintain proper cholesterol levels and peak energy levels. Food enzymes such as digestive enzymes are not entirely new. They have already been known to exist since the time of Hippocrates. It has also been long recognized that a lot of illnesses are related to improper diet and poor nutrition. This means that the " you are what you eat" thing was already known.

Digestive enzymes naturally protect us from illnesses. This is the second reason why we should have digestive enzyme therapy. Digestive enzymes have a great effect on our entire immune function. Digestive enzymes that are contained in white blood cells such as lipase, protease, amylase, alkaline phospatase and peptidase are part of the pancreatic juices and they all increase immune function.

Digestive enzymes are used to treat various illnesses too. This is the third reason why we should have digestive enzyme therapy.

Digestive enzymes are also essential if you want to achieve and maintain healthy skin. This is the fourth reason. Digestive enzymes help improve skin, hair and nails by increasing the blood supply to the skin and body. Then better digestion also improves circulation, and circulation helps bring the right nutrients to the skin as well as clean the waste products that make skin dull and wrinkled.

And the last reason, digestive enzymes is used to treat obesity and overweight. Digestive enzymes like lipase breaks down and dissolves the fat that is stored in our bodies and transforms them into energy. Without lipase, fat accumulates and is stored in arteries, organs and capillaries.

Protease also breaks down proteins and eliminates toxins. If your body has too much toxins, your body also stores excess fat. That is why protease's function is important in losing fat.

Read More

Sex gives clues to new lung cancer treatment

Research into an enzyme that produces a hormone released after sex has inspired Australian National University chemists to create new treatments for small-cell lung cancer.

Led by Professor Chris Easton and PhD student Ms. Lucy Cao from the ARC Centre of Excellence for Free Radical Chemistry and Biotechnology at ANU, the team are working to reduce the number of small-cell lung cancer deaths by building new drugs that target the biology underlying the disease. Their work has been published in the latest edition of The Royal Society Chemistry journal, Medicinal Chemistry Communications.

“Given that one in every 28 Australians are diagnosed with lung cancer and it is the most common cause of cancer death, there is a real need to develop new pharmaceuticals to treat this disease. Although it is still early days our results are very promising,” said Professor Easton.

The team are investigating an enzyme, known as PAM, which activates a number of important peptide hormones. These include calcitonin, which promotes cell proliferation, and oxytocin, dubbed the ‘love hormone’, as it produces feelings of contentment following orgasm. Imbalances in peptide hormones have been shown to cause inflammatory diseases, asthma, and various cancers.

Read More

Blood test to spot cancer gets big boost

A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones is moving one step closer to being available at your doctor’s office.

Boston scientists who invented the test and health care giant Johnson & Johnson will announce Monday that they are joining forces to bring it to market. Four big cancer centers also will start studies using the experimental test this year.

Stray cancer cells in the blood mean that a tumor has spread or is likely to, many doctors believe. A test that can capture such cells has the potential to transform care for many types of cancer, especially breast, prostate, colon and lung.

source: Lung Cancer Foundation

Read More

Enzyme could be a key to stopping the cancer

We are able to show that caloric restriction slows down aging by preventing an enzyme, peroxiredoxin, from being inactivated. This enzyme is also extremely important in counteracting damage to our genetic material," says Mikael Molin of the Department of Cell and Molecular Biology.


By gradually reducing the intake of sugar and proteins, without reducing vitamins and minerals, researchers have previously shown that monkeys can live several years longer than expected. The method has also been tested on everything from fishes and rats to fungi, flies and yeasts with favourable results. Caloric restriction also has favourable effects on our health and delays the development of age-related diseases. Despite this, researchers in the field have found it difficult to explain exactly how caloric restriction produces these favourable effects.

Using yeast cells as a model, the research team at the University of Gothenburg has successfully identified one of the enzymes required. They are able to show that active peroxiredoxin 1, Prx1, an enzyme that breaks down harmful hydrogen peroxide in the cells, is required for caloric restriction to work effectively.
The results, which have been published in the journal Molecular Cell, show that Prx1 is damaged during aging and loses its activity.

Caloric restriction counteracts this by increasing the production of another enzyme, Srx1, which repairs Prx1. Interestingly, the study also shows that aging can be delayed without caloric restriction by only increasing the quantity of Srx1 in the cell. Repair of the peroxiredoxin Prx1 consequently emerges as a key process in aging.
"Impaired Prx1 function leads to various types of genetic defects and cancer. Conversely, we can now speculate whether increased repair of Prx1 during aging can counteract, or at least delay, the development of cancer."

Peroxiredoxins have also been shown to be capable of preventing proteins from being damaged and aggregating, a process that has been linked to several age-related disorders affecting the nervous system, such as Alzheimer's and Parkinson's. The researchers are accordingly also considering whether stimulation of Prx1 can reduce and delay such disease processes.

* source ScienceDaily (Oct. 31, 2011)

Read More